Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.7K Hold
720
﹤0.01% 227
2026
Q1
$39.7K Hold
720
﹤0.01% 206
2025
Q4
$35.3K Sell
720
-240
-25% -$11.2K ﹤0.01% 211
2025
Q3
$41.4K Buy
+960
New +$37.5K ﹤0.01% 218
2024
Q1
Sell
-165
Closed -$6.12K 329
2023
Q4
$6.12K Buy
+165
New +$5.92K ﹤0.01% 240
2018
Q4
Sell
-80
Closed -$4K 362
2018
Q3
$4K Hold
80
﹤0.01% 254
2018
Q2
$4K Hold
80
﹤0.01% 247
2018
Q1
$4K Hold
80
﹤0.01% 260
2017
Q4
$4K Hold
80
﹤0.01% 232
2017
Q3
$4K Sell
80
-221
-73% -$11.2K ﹤0.01% 222
2017
Q2
$16K Buy
301
+221
+276% +$11.8K ﹤0.01% 169
2017
Q1
$4K Hold
80
﹤0.01% 182
2016
Q4
$4K Sell
80
-160
-67% -$7.9K ﹤0.01% 202
2016
Q3
$13K Buy
+240
New +$13.2K ﹤0.01% 176

Other funds holding GSK

Country Trust Bank's GSK Position: Q2 2026 in Review

Country Trust Bank held its GSK (GSK) position steady in Q2 2026 at 720 shares worth $37.7K. The position accounts for ﹤0.01% of the portfolio, ranked #227.

Country Trust Bank first reported a position in GSK in Q3 2016 and has held it in 14 quarters since. The position peaked at $41.4K in Q3 2025. 399 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Country Trust Bank held 720 shares of GSK worth $37.7K as of Q2 2026.
  • Country Trust Bank left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Country Trust Bank's portfolio in Q2 2026, its #227 holding.
  • Country Trust Bank first reported a position in GSK in Q3 2016 and has held it in 14 quarters since.
  • Country Trust Bank's GSK position peaked at $41.4K in Q3 2025.
  • 399 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Country Trust Bank's 13F filing for Q2 2026, filed 15 Jul 2026.